Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v5-FR
Language English French
Date Updated 2022-09-23 2022-06-30
Drug Identification Number 02239835 02239835
Brand name TEVA-AMIODARONE TEVA-AMIODARONE
Common or Proper name TEVA-AMIODARONE 200MG TABLETS TEVA-AMIODARONE 200MG TABLETS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C01BD C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-16 2022-06-16
Estimated end date 2022-09-20 2022-08-31
Actual end date 2022-09-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments